Drugs developed to treat Alzheimer’s disease could be repurposed to prevent damage caused to blood vessels in people with Type 2 diabetes after researchers discovered
According to CB Insights, a business intelligence platform, “Covid-19 is unsurprisingly catalyzing the adoption of contactless biometrics. Big tech companies and others are now in the
Dexcom’s president, Kevin Sayer, on what else can be gained from CGM sensors. By Sue Marshall. There has been more news from the Dexcom camp.
PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, have announced a strategic partnership with Senseonics Holdings, a medical technology company focused on
Companion Medical will help the company expand its diabetes management offerings, as reported by Catherine Roberts and Joe Carlson for the Star Tribune newspaper in
Behaviour change platform Changing Health has been appointed by NHS England to develop a free, personalised NHS programme for the 3.4 million people living with
Diabetes Research and Wellness Foundation (DRWF) is the latest organisation to add podcasts to its range of communications. Why Podcasts? Podcast audiences are growing, Apple Podcasts
There’s an update with Dexcom’s CEO Kevin Sayer (p.8) about other uses for CGM beyond measuring blood glucose. I’ve also interviewed the creator of a
There is strong public support for the government to address obesity after emerging research suggests there is a link between obesity and adverse outcomes from Covid-19.
Preliminary data from the US suggest that many people with Type 1 diabetes who contract Covid-19 can manage the illness at home, and overall mortality
